<DOC>
	<DOCNO>NCT01555580</DOCNO>
	<brief_summary>The purpose study determine whether drug Leukine ( GM-CFS ) safe tolerated patient autoimmune myasthenia gravis ( MG ) .</brief_summary>
	<brief_title>A Pilot Study Granulocyte-Macrophage Colony-Stimulating Factor ( GM-CSF ) Generalized Myasthenia Gravis</brief_title>
	<detailed_description>Twelve patient age 18-80 symptomatic generalize autoimmune MG treat medication suppresses immune system , prednisone , enter study UIC two year period . The study involve screen visit visit baseline day 5 , 15 , 30 , 45 , 60 , 90 , 120 . The study drug , Leukine ( GM-CFS ) , give injection . Subjects give one dose GM-CSF every day 10 day . Study visit include muscle testing , immunologic study quality-of-life study .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<criteria>Must 18 80 year age Established diagnosis myasthenia base : presence fatigable weakness ocular , oropharyngeal , and/or limb muscle AND presence abnormal acetylcholine receptor bind antibody ≥ 0.4 nmol/l . Patients childbearing potential must agree use medically acceptable form contraception define consistent use oral contraceptive medication history tubal ligation men sexual relationship woman least 8 week follow completion study . Patient designee must ability selfinject investigational product If thymectomized , procedure must perform least one year prior screen . Dose current anticholinesterase drug must constant 2 week prior screen . If take prednisone , dose must stable ≥4 week prior screen . Exclusion criterion : exclusively ocular MG ( MGFA Class I ) severe respiratory and/ swallow muscle weakness ( MGFA Class Vb V ) presence thymoma Must receive plasm exchange IVIG within 4 week screen Must receive immunomodulating agent within 4 week screen , include Azathioprine ( Imuran ) , Cyclosporine ( Sandimmune , Neoral ) , Mycophenolate mofetil ( CellCept ) , GMCSF ( Filgrastim ; Neupogen ; pegfilgrastim , sargramostim ) , chronic immunosuppressive agent History tuberculosis evidence latent tuberculosis ( positive PPD skin test chest Xray evidence tuberculosis ) vital capacity le 1.2 liter supplemental oxygen therapy . severe comorbidities include lung disease , stroke , congestive heart failure severity , myocardial infarction , EKG abnormality , uncontrolled hypertension ( sit systolic BP &lt; 80 &gt; 160 mm Hg diastolic BP &gt; 100 mm Hg , unstable angina pectoris , hepatic renal disease , insulindependent diabetes mellitus , history cancer ( insitu cervical cancer resect , cutaneous basal cell squamous cell carcinoma ) , open cutaneous ulcer , know hepatitis B surface antigen ( HbsAg ) hepatitis C virus ( HCV ) positive , concurrent medical condition , would make unsafe subject participate trial interfere interpretation result . Laboratories value , time screen visit time study opinion Investigator would preclude participation study include : serum creatinine &gt; 2.5 mg/dL , serum potassium &lt; 3.5 mmol/L &gt; 5.5 mmol/L , serum aspartate transaminase ( AST ) , alanine transaminase ( ALT ) , alkaline phosphatase ( ALP ) &gt; 3 time upper limit normal , platelet count &lt; 100,000/mm3 , WBC count &lt; 3,000 cells/mm3 , Hemoglobin , hematocrit , red blood cell count outside 30 % upper low limit normal Receipt live vaccine within 3 month screen participation another investigational drug study within 90 day screen . know hypersensitivity GMCSF component Known HIVpositive status know history immunosuppressing disease . Any mycobacterial disease . Active severe infection within 4 week screen visit , screen baseline visit . Untreated Lyme disease . History TB TB exposure , chronic hepatitis B hepatitis C , SLE , history multiple sclerosis , transverse myelitis , optic neuritis epilepsy . History recent alcohol substance abuse ( &lt; 1 year ) Pregnant lactate female History noncompliance therapy abnormal mental status sufficient exclude inform consent History opportunistic infection include limited Pneumocystis carinii , aspergillosis , histoplasmosis , atypical mycobacterium History Sickle cell disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>myasthenia gravis</keyword>
	<keyword>autoimmune</keyword>
	<keyword>GM-CSF</keyword>
</DOC>